Application 217070
- Type
- NDA
- Sponsor
- AUROBINDO PHARMA USA
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | ABACAVIR; DOLUTEGRAVIR; LAMIVUDINE | ABACAVIR; DOLUTEGRAVIR; LAMIVUDINE | TABLET; ORAL | 60MG;5MG;30MG | No | No |
Documents#
| Document | Submission type | Date |
|---|---|---|
| 75078 | ORIG | 2023-08-15 |